BMI and Cosmetic Surgery Eligibility: Procedure-by-Procedure Thresholds

Most UK cosmetic surgery providers, Centre for Surgery included, apply a BMI ceiling when deciding whether to operate. The standard threshold is a BMI of 30 for most procedures, with some flexibility up to 32 for facial work and stricter limits for high-risk procedures. This isn’t an arbitrary policy. It reflects a substantial body of evidence linking elevated BMI to specific, measurable increases in surgical risk, and the limits are set where the risk profile shifts from acceptable to disproportionate for elective work.

This guide explains what BMI is, why it matters specifically for cosmetic surgery, what the procedure-by-procedure thresholds are at our clinic, and what the realistic options look like if you are currently above the threshold. If you are already researching individual operations, our patient resources library covers each procedure in detail, and our guide to preparing for surgery covers the wider pre-operative picture.

What is BMI and how is it calculated?

Body Mass Index is calculated as weight in kilograms divided by height in metres squared. The standard categories used in UK clinical practice are:

• Under 18.5 — underweight
• 18.5 to 24.9 — healthy weight
• 25 to 29.9 — overweight
• 30 to 34.9 — obesity class I
• 35 to 39.9 — obesity class II
• 40 and above — obesity class III

BMI is an imperfect measure of individual health. It does not distinguish between muscle and fat, can over-estimate body fat in muscular patients, and under-estimate it in patients with low muscle mass. For population-level statistics and elective surgery risk assessment, however, it remains the most widely used standardised metric, and the surgical risk data on which our thresholds are based uses BMI as its variable.

Does a high BMI increase cosmetic surgery risk?

Yes, and the size of the increase has been measured. The largest published study on the question reviewed outcomes in 127,961 aesthetic surgery patients (Gupta et al., Aesthetic Surgery Journal, 2016)^[1]. It counted major complications — those requiring an emergency department visit, hospital admission, or a return to theatre within 30 days — and found the rate climbed steadily with BMI:

• BMI under 18.5 — 1.4% major complication rate
• BMI 18.5 to 24.9 — 1.6%
• BMI 25 to 29.9 — 2.3%
• BMI 30 to 39.9 — 3.1%
• BMI 40 and above — 4.2%

After controlling for age, gender, smoking, diabetes, combined procedures and type of surgical facility, both overweight (BMI 25–29.9) and obesity (BMI 30+) remained independent predictors of complications. The adjusted relative risks were 1.63 and 2.73 for infection, and 1.67 and 2.56 for venous thromboembolism. In other words, a patient at BMI 30 or above is roughly two and a half times more likely to develop a post-operative infection or a clot than a patient of healthy weight having the same operation.

The same study broke the figures down by procedure. Among overweight and obese patients, complication rates were significantly higher for abdominoplasty (3.5%), lower body lift (8.8%) and combined breast and body procedures (4.2%), while liposuction alone remained low at 0.9%. That spread is the reason our thresholds differ by operation rather than applying one number across the board.

The mechanisms behind those numbers are well understood:

• Surgical site infection. Impaired immune response, reduced local tissue oxygenation, and more “dead space” in the wound when adipose tissue is closed all contribute to higher infection rates in patients with elevated BMI.
• Venous thromboembolism (deep vein thrombosis and pulmonary embolism). Elevated BMI is an independent VTE risk factor on its own, and adds to the baseline VTE risk of surgery and post-operative immobility.
• Wound dehiscence and delayed healing. Particularly relevant after abdominoplasty and any procedure with long incisions under tension. Adipose tissue heals less reliably than lean tissue.
• Seroma formation. Larger dissection planes and more adipose disruption produce more fluid collection post-operatively.
• Anaesthetic complications. Higher BMI is associated with more difficult airway management, higher rates of respiratory complications, and increased arrhythmia risk. We use TIVA (total intravenous anaesthesia) as standard for procedures requiring general anaesthesia, which avoids inhalational agents, but airway considerations still apply.
• Aesthetic outcome. Beyond safety, surgery on a patient who has not stabilised their weight produces less predictable and less durable aesthetic results. Subsequent weight loss can leave loose skin; subsequent weight gain can distort the surgical result.

The clinical question is not whether higher BMI is associated with higher risk — that is settled. It is where to draw the line for elective cosmetic procedures. The general consensus across UK consultant plastic surgery practice sits around BMI 30 for most body procedures, and that is where our own limits sit.

What BMI do you need for cosmetic surgery?

Our standard limits, applied at consultation booking and confirmed at the in-person assessment, are as follows:

• Liposuction: BMI under 30, ideally under 28. Liposuction is a body contouring procedure, not a weight loss intervention; results are dramatically better and complications lower when patients are close to their stable target weight. See liposuction.
• Tummy tuck (abdominoplasty): BMI under 30. This is the procedure where the evidence for a firm limit is strongest — abdominoplasty carried one of the highest complication rates in overweight patients in the 127,961-patient series. We will sometimes consider patients with a BMI of 30 to 32 after significant documented weight loss (typically >60 lbs lost and weight stable for 6 months). See tummy tuck.
• Mummy makeover: BMI under 30. Combined procedures multiply risk independently of BMI. In a linked analysis of 2,294 arm lift patients from the same database, combining procedures raised the risk of any complication more than threefold (Nguyen et al., Aesthetic Surgery Journal, 2016)^[2], which is why combined cases require tighter patient selection. See mummy makeover.
• Brazilian Butt Lift (BBL): BMI under 30, and a minimum of around 22, since some donor fat volume is needed. See Brazilian Butt Lift — and the section below on why technique matters more than BMI for this operation.
• Breast augmentation, breast lift, breast reduction: BMI under 30 preferred; up to 32 considered for some breast reduction cases where the breast volume itself is contributing to the elevated BMI.
• Gynaecomastia surgery: BMI under 30 preferred; some flexibility for true gynaecomastia (glandular) cases. Pseudogynaecomastia (fatty) cases generally require weight loss first. See gynaecomastia surgery.
• Rhinoplasty, blepharoplasty, otoplasty, facelift: Up to BMI 32 generally acceptable, for reasons set out below.
• Labiaplasty, clitoral hood reduction: Up to BMI 32. Local anaesthetic options are often available, which further reduces operative risk.

These are guidelines, not hard cut-offs at the third decimal place. A patient at BMI 30.2 will be assessed individually rather than declined automatically. Patients well above the threshold are not suitable for an immediate booking, and we will be honest about that at the initial enquiry rather than waste a consultation fee.

Why is the BMI limit higher for facial surgery?

Facial procedures involve smaller surgical fields, shorter operating times and earlier mobilisation, so the VTE risk that drives much of the concern in body surgery is substantially lower. That is the honest basis for the more permissive threshold.

It is worth being clear that this does not mean BMI is irrelevant to facial surgery. In a study of 11,300 facelift patients from the same database, a BMI of 25 or above was an independent risk factor for post-operative infection, with a relative risk of 2.8 (Gupta et al., Aesthetic Surgery Journal, 2015)^[3]. Facelift remains a very safe operation overall — the study found an overall major complication rate of 1.8% — but the infection risk associated with elevated BMI does not disappear simply because the operation is above the neck. The higher facial threshold is a considered trade-off, not an indication that weight stops mattering.

BBL safety: why technique matters more than BMI

Gluteal fat grafting has historically carried the highest mortality of any cosmetic operation, driven by pulmonary fat embolism when fat is injected into or beneath the gluteal muscle. That risk is primarily a function of surgical technique rather than patient BMI.

Following technique recommendations issued in 2017 — injecting into the subcutaneous plane only, using cannulas of 4.1mm or larger, and avoiding downward cannula angulation — the reported incidence of fat embolism fell from around 1 in 1,030 cases to 1 in 2,492, with mortality falling from approximately 1 in 3,448 to 1 in 14,952 (Rios and Gupta, Aesthetic Surgery Journal, 2020)^[4]. We follow those recommendations. The BMI window for BBL exists mainly to ensure adequate donor fat at the lower end and to keep general surgical risk acceptable at the upper end — it is not the principal safety control for this operation.

Why we apply the threshold at the enquiry stage

The patient coordinator screening described in our guide on from enquiry to consultation includes a BMI check before a consultation is booked. We do this for two reasons. First, it avoids you paying for a consultation that ends with a deferral recommendation. Second, it gives us the opportunity to discuss preparatory weight loss options, where appropriate, before you arrive.

This is not a judgement on weight or health more broadly. It is a recognition that elective cosmetic surgery is a discretionary intervention with a finite risk profile, and the appropriate window for it is when that profile is as low as it can reasonably be.

What if your BMI is too high for surgery?

Several options exist depending on how much weight needs to come off and what your timeline looks like:

• Short-term weight optimisation (5–10 lbs to threshold). Three to four months of sustained dietary changes and increased activity is usually sufficient. We can confirm a target weight at the initial enquiry call and book your consultation for a date when you expect to be at it.
• Moderate weight loss (1–2 stone to threshold). Plan for 6 to 12 months. A structured approach — calorie tracking, increased protein intake, resistance training — produces more durable results than rapid weight loss. Our guide on how to lose weight before cosmetic surgery covers the practical approach.
• Substantial weight loss (3+ stone to threshold). A longer programme is appropriate, potentially involving GP support, structured weight management services, or medical weight loss interventions. GLP-1 medications have changed the options available here significantly. Discuss this route with your GP first, and read the section below on what it means for your surgery date.
• Post-bariatric patients. Patients who have already achieved significant weight loss through bariatric surgery and have stabilised at a BMI of 30 to 32 are often suitable for body contouring procedures, including abdominoplasty and breast surgery, with appropriate planning. The key requirements are 18 months of stable weight, adequate nutritional status, and no ongoing medical complications. Weight stabilisation, nutritional optimisation and thromboprophylaxis are all established components of pre-operative assessment in this group (Humar and Robinson, Clinics in Plastic Surgery, 2024)^[5], and patients who have lost a large amount of weight carry a higher baseline thromboembolic risk that we plan for specifically.

What does not work, in our experience, is rapid weight loss in the weeks immediately before surgery. This depletes protein and micronutrient stores in a way that impairs wound healing, and the weight is usually not stable, which compromises the aesthetic result. If your weight is well above threshold, give it time.

Do you need to stop GLP-1 weight loss medication before surgery?

This now affects a significant proportion of patients reaching their target weight, and it is the single most important thing to tell us if it applies to you.

GLP-1 receptor agonists slow gastric emptying. That is part of how they work, but it means the stomach may still contain food after a standard pre-operative fast, which raises the risk of aspiration under anaesthesia. In a study of 1,094 patients undergoing endoscopy under sedation or general anaesthesia, increased residual gastric content was found in 20.3% of those who had taken a GLP-1 medication within 30 days, compared with 3.2% of those who had not (Santos et al., Journal of Clinical Anesthesia, 2024)^[6]. Residual gastric content only became comparable to non-users after more than 14 days off the medication, and more than 21 days in patients with ongoing nausea, bloating or dyspepsia. A case has been reported of a procedure being abandoned on the day after food was found in the stomach despite correct fasting (Fujino et al., Cureus, 2023)^[7].

The practical implications:

• Tell your patient coordinator and your anaesthetist if you are taking, or have recently taken, a GLP-1 medication — including if you stopped shortly before surgery.
• Expect to be advised to stop it for a defined interval before your operation. The exact interval is an individual clinical decision made by your anaesthetist.
• Do not stop or alter a prescribed medication on the basis of a web page. Raise it with your prescriber and with us, and we will coordinate the timing.
• Concealing GLP-1 use is dangerous. It is not a reason for us to decline your surgery; it is a reason to plan your fasting and airway management differently.

Can you have cosmetic surgery with a low BMI?

Usually yes, and the risk picture here is more nuanced than is often presented. In the 127,961-patient series, patients with a BMI below 18.5 had a major complication rate of 1.4% — marginally lower than the healthy-weight group. Being underweight is not, on that evidence, associated with a higher rate of serious early post-operative complications.

Our caution with underweight patients therefore rests on different grounds, and we are explicit about them rather than implying a risk figure that the data does not support:

• Nutritional status. Wound healing depends on adequate protein, iron, zinc and vitamin C. Where intake is inadequate, we address that before operating — a consideration about healing quality, not about emergency complications.
• Technical feasibility. Reduced subcutaneous tissue limits some procedures outright. Fat transfer operations, including BBL and fat transfer to the breasts or face, require sufficient donor volume to be viable at all.
• Eating disorder screening. A low BMI in a patient seeking body-focused surgery warrants careful assessment. We do not operate on patients with active eating disorders, and we will defer surgery while underlying nutritional and psychological factors are addressed. This is also part of the wider psychological screening described in our guide on body dysmorphia and cosmetic surgery.

The role of BMI in consent

Even when a patient is within the BMI threshold, BMI remains a variable discussed during informed consent. A patient at BMI 29.5 has a measurably higher complication risk than a patient at BMI 23, even though both are considered suitable — the figures above show the gradient is continuous rather than switching on at 30. This is part of the realistic risk discussion the surgeon will have with you at consultation, and is reflected in the procedure-specific written consent material.

Booking a consultation

If you are within or close to the relevant BMI threshold and would like to book a consultation, call 020 7993 4849 or use the contact form. If you are well above the threshold and want to discuss a longer-term plan, the same channels work — we will give you honest advice about timing rather than book a consultation that isn’t yet appropriate.

For funding information, see finance options through Chrysalis Finance, our FCA-regulated finance partner, subject to status. We are based at 95–97 Baker Street, Marylebone.

References

Sources identified via PubMed. Each entry links to the original paper.

1. Gupta V, Winocour J, Rodriguez-Feo C, Bamba R, Shack RB, Grotting JC, Higdon KK. Safety of aesthetic surgery in the overweight patient: analysis of 127,961 patients. Aesthetic Surgery Journal 2016;36(6):718–729. doi:10.1093/asj/sjv268
2. Nguyen L, Gupta V, Afshari A, Shack RB, Grotting JC, Higdon KK. Incidence and risk factors of major complications in brachioplasty: analysis of 2,294 patients. Aesthetic Surgery Journal 2016;36(7):792–803. doi:10.1093/asj/sjv267
3. Gupta V, Winocour J, Shi H, Shack RB, Grotting JC, Higdon KK. Preoperative risk factors and complication rates in facelift: analysis of 11,300 patients. Aesthetic Surgery Journal 2016;36(1):1–13 (published online 2015). doi:10.1093/asj/sjv162
4. Rios L, Gupta V. Improvement in Brazilian butt lift (BBL) safety with the current recommendations from ASERF, ASAPS, and ISAPS. Aesthetic Surgery Journal 2020;40(8):864–870. doi:10.1093/asj/sjaa098
5. Humar P, Robinson B. Preparing patients for body contouring surgery and postoperative surveillance for deep venous thrombosis. Clinics in Plastic Surgery 2024;51(1):1–6. doi:10.1016/j.cps.2023.06.007
6. Santos LB, Mizubuti GB, da Silva LM, Silveira SQ, Nersessian RSF, Abib ACV, et al. Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retrospective single center observational study. Journal of Clinical Anesthesia 2024;99:111668. doi:10.1016/j.jclinane.2024.111668
7. Fujino E, Cobb KW, Schoenherr J, Gouker L, Lund E. Anesthesia considerations for a patient on semaglutide and delayed gastric emptying. Cureus 2023;15(7):e42153. doi:10.7759/cureus.42153

Related reading

• How to lose weight before cosmetic surgery
• Factors that influence your cosmetic surgery results
• Essential preparations before your plastic surgery

Centre for Surgery · CQC-regulated · GMC-registered surgeons · 95–97 Baker Street, Marylebone, London W1U 6RN · 020 7993 4849 · Book a consultation · Finance available, subject to status